Optimizing oncology: The future of treatment studies
Press Conference footage of the first Lancet Oncology Commission presented to the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden. It brings together 37 experts from HIC countries in a comprehensive analysis that points out where these countries have their lost their way in managing cancer costs, and future challenges. The Commission lead author is Professor Richard Sullivan from the King's Health Partners Integrated Cancer Centre, a collaboration between King's College London and its partner NHS Foundation Trusts – Guy's and St Thomas' and King's College Hospital, London, UK.
Optimizing oncology: The future of treatment studies
Advancements in head and neck cancer treatment in India
Enhancing head and neck oncology: Key insights from the conference
Importance of MRD in newly developed multiple myeloma
Best practice in HRRm testing in patients with metastatic prostate cancer
EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects
The treatment of cervical cancer in the presence of HIV in Sub-Saharan Africa